SERIES

CAR-T Series

Cell therapy at the frontier — entering the in vivo era

---

CAR-T cell therapy is a revolutionary treatment that genetically modifies a patient’s own T cells to attack cancer. The recent focus on “in vivo CAR-T” is accelerating the race to eliminate manufacturing bottlenecks. This series covers the front lines.

📋 Reading Path

1. Basics: CAR-T Fundamentals and Current State
2. ex vivo: Approved CAR-T Therapies
3. in vivo 1–6: Complete Overview of in vivo CAR-T
4. 2025 Race: Latest Updates
5. Future: Next-Generation Cell Therapy

📚 All Articles in This Series

→ View all articles

🔗 Related Series

Bispecific Antibody Series / ADC (Antibody-Drug Conjugate) Series / KRAS Deep Dive / Oncology Approval News